Valuation: Dr. Martens plc

Market Cap 496M 649M 592M 545M 931M 60.11B 981M 6.64B 2.64B 32.8B 2.43B 2.38B 103B P/E 2027 *
14.4x
P/E 2028 * 11.4x
Enterprise Value 703M 919M 838M 772M 1.32B 85.12B 1.39B 9.4B 3.74B 46.45B 3.44B 3.38B 146B EV / Sales 2027 *
0.97x
EV / Sales 2028 * 0.92x
Free-Float
57.16%
Yield 2027 *
4.89%
Yield 2028 * 5.13%
1 day-4.22%
1 week-3.51%
Current month-20.43%
1 month-22.90%
3 months-39.02%
6 months-21.39%
Current year-31.85%
1 week 51.8
Extreme 51.8
57
1 month 50.8
Extreme 50.8
70.7
Current year 50.8
Extreme 50.8
90
1 year 50.8
Extreme 50.8
90
3 years 43.02
Extreme 43.02
120
5 years 43.02
Extreme 43.02
448.2
10 years 43.02
Extreme 43.02
521.6
Manager TitleAgeSince
Chief Executive Officer 55 2025-01-05
Director of Finance/CFO 53 2024-05-12
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 53 2020-12-31
Director/Board Member 55 2025-07-09
Director/Board Member 52 2020-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
5/29/26 Free

Chief Executive Officer

2,732,653 0.2823%
5/29/26 Free

Chief Financial Officer

2,100,151 0.2170%
5/13/26 Buy

Chief Financial Officer

233 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-4.22%-3.51%-36.03%-54.09% 679M
-4.11%-12.82%-47.45%-68.93% 50.99B
-4.18%-6.75%+7.91%-8.15% 32.59B
-4.31%-15.88%+14.09%+206.92% 18.91B
-1.28%-7.80%-6.11%-24.64% 10.54B
-2.76%-9.37%-30.79%+8.59% 10.3B
-1.68%-1.41%+95.36%+69.63% 7.19B
-3.75%-2.06%-39.29%-26.54% 6.48B
-2.59%-6.19%-16.94%-19.86% 6.12B
-5.33%-10.50%+50.05%-55.71% 4B
Average -3.29%-4.89%-0.92%+2.72% 15B
Weighted average by Cap. -3.59%-6.65%-12.00%-0.61%

Financials

2027 *2028 *
Net sales 723M 946M 862M 794M 1.36B 87.56B 1.43B 9.67B 3.85B 47.78B 3.54B 3.47B 150B 751M 983M 896M 826M 1.41B 91.04B 1.49B 10.05B 4B 49.68B 3.68B 3.61B 156B
Net income 36.1M 47.24M 43.05M 39.66M 67.74M 4.37B 71.39M 483M 192M 2.39B 177M 173M 7.49B 44.77M 58.58M 53.39M 49.19M 84.01M 5.42B 88.53M 599M 238M 2.96B 219M 215M 9.29B
Net Debt 206M 270M 246M 227M 387M 25B 408M 2.76B 1.1B 13.65B 1.01B 992M 42.82B 194M 254M 231M 213M 364M 23.51B 384M 2.6B 1.03B 12.83B 951M 933M 40.26B
Projected Income Statement - Annual - Dr. Martens plc
Logo Dr. Martens plc
Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company's segments include Europe, the Middle East and Africa (EMEA); Americas; and Asia-Pacific (APAC). Its product segments include boots, shoes, sandals, and bags & other. Its boots offerings include the 1460 8-eye boot, 2976 Chelsea boot, Jadon, Bex and Sinclair. Its shoes offerings include 1461 3-eye shoe and the Adrian tassel loafer, as well as franchises/families such as Buzz and Lowell. Its sandals range includes Blaire and Gryphon silhouettes and also includes the mules range, led by the Zebzag. Its bag range is focused on key silhouettes of leather bags, such as the Kiev backpack, the heart-shaped bag and its weekender bag. This category also includes socks, laces and shoe care. The Company offers its products through direct-to-consumer channel via its ecommerce platforms and its stores, among others.
Employees
3,600
Date Price Change Volume
26-11-20 GBX 52.20 -4.22% 3,790,376
26-11-19 GBX 54.50 -2.85% 3,844,261
26-11-18 GBX 56.10 +1.63% 5,430,800
26-11-17 GBX 55.20 +1.85% 6,208,716
26-11-16 GBX 54.20 +2.65% 6,417,945
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Dr. Martens plc
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
0.5220GBP
Average target price
0.7760GBP
Spread / Average Target
+48.66%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Dr. Martens plc
  1. Stock Market
  2. Stocks
  3. DOCS Stock